Human ARG1 (Arginase-1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05888P
SDS-PAGE analysis of Human ARG1 (Arginase-1) - Recombinant Protein, CAT# BLT-05888P, showing >85% purity under 15% SDS-PAGE (Reduced)
Human ARG1 (Arginase-1) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-05888P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $1,030 (Fall Promotion) |
| 1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Arginase (ARG1) Protein |
| Product Overview | This recombinant human Arginase (ARG1) protein includes amino acids 1-322aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | P05089 |
| Recommended Name | Arginase-1 |
| Gene Name | ARG1 |
| Synonyms | ARG1 |
| Species | Human |
| Predicted Molecular Mass | 36.7 kDa |
| Expression System | Mammalian Cell |
| Expression Range | 1-322aa |
| Tag | N-His&C-MYC |
| Purity | >85% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Signal Transduction |
| Target Function | Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys.; Functions in L-arginine homeostasis in nonhepatic tissues characterized by the competition between nitric oxide synthase (NOS) and arginase for the available intracellular substrate arginine. Arginine metabolism is a critical regulator of innate and adaptive immune responses. Involved in an antimicrobial effector pathway in polymorphonuclear granulocytes (PMN). Upon PMN cell death is liberated from the phagolysosome and depletes arginine in the microenvironment leading to suppressed T cell and natural killer (NK) cell proliferation and cytokine secretion. In group 2 innate lymphoid cells (ILC2s) promotes acute type 2 inflammation in the lung and is involved in optimal ILC2 proliferation but not survival. In humans, the immunological role in the monocytic/macrophage/dendritic cell (DC) lineage is unsure. |
| Subcellular Location | Cytoplasm. Cytoplasmic granule. |
| Protein Family | Arginase family |
| Associated Diseases | Argininemia (ARGIN) |
| Tissue Specificity | Within the immune system initially reported to be selectively expressed in granulocytes (polymorphonuclear leukocytes [PMNs]). Also detected in macrophages mycobacterial granulomas. Expressed in group2 innate lymphoid cells (ILC2s) during lung disease. |
